Showing 4921-4930 of 6978 results for "".
- Novartis Announces EU Approval of Xolair for Chronic Spontaneous Urticaria Patients Unresponsive to Antihistamineshttps://practicaldermatology.com/news/20140307-novartis_announces_eu_approval_of_xolair_for_chronic_spontaneous_urticaria_patients_unresponsive_to_antihistamines/2459322/
- Michelson Diagnostics Launches Enhanced Software for VivoSight OCT Scannerhttps://practicaldermatology.com/news/20140219-michelson_diagnostics_launches_enhanced_software_for_vivosight_oct_scanner/2459339/Michelson Diagnostics recently launched its upgraded VivoSight Optical Coherence Tomography (OCT) scanner with a new software technology that provides additional f
- Cosmetic Surgery Forum Offers Early-Bird Registrationhttps://practicaldermatology.com/news/20140204-cosmetic_surgery_forum_offers_early-bird_registration/2459349/
- Oculus Innovative Sciences Receives European CE Mark for Use of Microcyn to Treat Mild to Moderate Acnehttps://practicaldermatology.com/news/20140204-oculus_innovative_sciences_receives_european_ce_mark_for_use_of_microcyn_to_treat_mild_to_moderate_acne/2459350/
- Study Finds Prevalence of Indoor Tanning Common in US, Europe, and Australiahttps://practicaldermatology.com/news/20140130-study_finds_prevalence_of_indoor_tanning_common_in_us_europe_and_australia/2459355/
- Merz Dermatology Announces Enhanced Naftin Co-Payment Savings Programhttps://practicaldermatology.com/news/20140117-merz_dermatology_announces_enhanced_naftin_co-payment_savings_program/2459370/
- Scioderm Initiates Phase IIB Study of SD-101 to Treat Epidermolysis Bullosahttps://practicaldermatology.com/news/20140107-scioderm_initiates_phase_iib_study_of_sd-101_to_treat_epidermolysis_bullosa/2459377/
- NIH Awards Icahn School of Medicine at Mount Sinai $2.7 Million for Eczema Researchhttps://practicaldermatology.com/news/20131126-nih_awards_icahn_school_of_medicine_at_mount_sinai_27_million_for_eczema_research/2459404/
- New Children's Book Explains Vascular Birthmarks and Celebrates that One-Of-A-Kind Childhttps://practicaldermatology.com/news/20131106-new_childrens_book_explains_vascular_birthmarks_and_celebrates_that_one-of-a-kind_child/2459423/
- Humira Found Effective for Hidradentis Suppurativahttps://practicaldermatology.com/news/20131011-humira_found_effective_for_hidradentis_suppurativa/2459436/Results from a post-hoc analysis of an investigational Phase II study found that Humira (adalimumab, AbbVie) induced significant response rate in adult patients with moderate to severe hidradenitis suppurativa (HS) after 16 weeks of therapy. Researchers used the HS-Physician Global Assessment (HS-P